Tasly Pharmaceutical Group (600535.SHG) Q2 2025 Earnings

28AprConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
0.12
0.16
0.2
0.24

Details

Expected EPS
0.22106071679999997
Actual EPS
0.2110125024
Surprise EPS
-0.01
Surprise Percent
+4.55%

Description

Tasly Pharmaceutical Group (600535.SHG) has reported earnings of 0.2110125024 per share for Q2 2025.

0 Comments

Share your thoughts